National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

AC-T regimen
A chemotherapy regimen consisting of doxorubucin hydrochloride (Adriamycin) and cyclophosphamide, followed by paclitaxel (Taxol), administered on either a dose-dense or sequential schedule and used as an adjuvant treatment for breast cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Adriamycin Cyclophosphamide-Taxol regimen



Previous:absorbable gelatin sponge, ABT-510, ABT-751, ABT-888, ABVD regimen
Next:acadesine, acarbose, Accutane, acetaminophen, acetylcysteine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov